PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 121 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $859,000 | -25.5% | 226,016 | -0.3% | 0.00% | 0.0% |
| Q4 2019 | $1,153,000 | +8.8% | 226,590 | +8.1% | 0.00% | 0.0% |
| Q3 2019 | $1,060,000 | -12.9% | 209,699 | +6.2% | 0.00% | 0.0% |
| Q2 2019 | $1,217,000 | +32.9% | 197,437 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $916,000 | +23.1% | 197,437 | +10.2% | 0.00% | 0.0% |
| Q4 2018 | $744,000 | -33.5% | 179,219 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $1,119,000 | -4.5% | 179,219 | +23.2% | 0.00% | 0.0% |
| Q2 2018 | $1,172,000 | +21.3% | 145,420 | +11.8% | 0.00% | 0.0% |
| Q1 2018 | $966,000 | +25.3% | 130,100 | +0.3% | 0.00% | 0.0% |
| Q4 2017 | $771,000 | -17.0% | 129,657 | +2.6% | 0.00% | 0.0% |
| Q3 2017 | $929,000 | +7.3% | 126,326 | -0.9% | 0.00% | 0.0% |
| Q2 2017 | $866,000 | -21.3% | 127,423 | +9.4% | 0.00% | 0.0% |
| Q1 2017 | $1,100,000 | +633.3% | 116,476 | +576.8% | 0.00% | – |
| Q4 2016 | $150,000 | +114.3% | 17,209 | +47.3% | 0.00% | – |
| Q3 2016 | $70,000 | +32.1% | 11,684 | -8.6% | 0.00% | – |
| Q2 2016 | $53,000 | -3.6% | 12,790 | 0.0% | 0.00% | – |
| Q1 2016 | $55,000 | -30.4% | 12,790 | 0.0% | 0.00% | – |
| Q4 2015 | $79,000 | +11.3% | 12,790 | 0.0% | 0.00% | – |
| Q3 2015 | $71,000 | -20.2% | 12,790 | 0.0% | 0.00% | – |
| Q2 2015 | $89,000 | +17.1% | 12,790 | 0.0% | 0.00% | – |
| Q1 2015 | $76,000 | -18.3% | 12,790 | 0.0% | 0.00% | – |
| Q4 2014 | $93,000 | +43.1% | 12,790 | 0.0% | 0.00% | – |
| Q3 2014 | $65,000 | – | 12,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|